Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Inventory Average of $11.6 million for Q1 2026, up 117.22% year-over-year from $5.3 million in Q1 2025, and down 6.65% quarter-over-quarter from $12.4 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $11.6 million for Q1 2026.
- In Q1 2026, Inventory Average rose 117.22% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (up 117.22% YoY), while the FY2025 annual figure was $8.8 million, up 51.93% from the prior year.
- Inventory Average for Q1 2026 stood at $11.6 million, down from $12.4 million in the prior quarter.
- The five-year high for Inventory Average was $12.4 million in Q4 2025, with the low at $5.3 million in Q1 2025.
- The 5-year median for Inventory Average is $7.3 million (2024), against an average of $8.1 million.
- The sharpest annual moves came in 2024 and 2025: Inventory Average slumped 40.08% in 2024, then soared 130.01% in 2025.
- Rigel Pharmaceuticals' Inventory Average stood at $8.1 million in 2022, then fell by 28.34% to $5.8 million in 2023, then retreated by 7.29% to $5.4 million in 2024, then jumped by 130.01% to $12.4 million in 2025, then slipped by 6.65% to $11.6 million in 2026.
- Business Quant data shows RIGL's Inventory Average at $11.6 million in Q1 2026, $12.4 million in Q4 2025, and $11.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.01 Mn |
| Mar 31, 2026 | 11.58 Mn |
| Dec 31, 2025 | 12.40 Mn |
| Sep 30, 2025 | 11.86 Mn |
| Jun 30, 2025 | 7.54 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 6.05 Mn |
| Dec 31, 2023 | 5.82 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 10.93 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 8.12 Mn |
| Sep 30, 2022 | 6.67 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Dec 31, 2021 | 6.83 Mn |
| Sep 30, 2021 | 6.93 Mn |